Evidence map›Paper›PMID 22311635›Full record

ArticleEuropean journal of immunology2012

Developmentally regulated expression of MEF2C limits the response to BCR engagement in transitional B cells.

Sarah F Andrews, Xuezhi Dai, Byoung Y Ryu, Tod Gulick, Bindu Ramachandran, David J Rawlings

Open access · greenAbstract read
In one paragraph

Article in European journal of immunology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.7field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 10 citations in OpenAlex.

  1. IPiScience · 2022
    Article
  2. Article
  3. Article
  4. Article
  5. Adaptor protein DOK3 promotes plasma cell differentiation by regulating the expression of programmed cell death 1 ligands.Proceedings of the National Academy of Sciences of the United States of America · 2014
    Article
  6. Review
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Sarah F AndrewsCenter for Immunity and Immunotherapies, Seattle Children's Research Institute, Seattle, WA, USA.
Xuezhi Dai
Byoung Y Ryu
Tod Gulick
Bindu Ramachandran
David J Rawlings
Seattle Children's Hospital · USSanford Burnham Prebys Medical Discovery Institute · USUniversity of Washington · US

Funding

Transduction of Human Stem and Progenitor CellsP01HL073104 · NHLBI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI KOHN, DONALD B · 2003 to 2013
$18.3M
Lentiviral Gene Therapy for Wiskott-Aldrich SyndromeR01AI071163 · NIAID · SEATTLE CHILDREN'S HOSPITAL · PI RAWLINGS, DAVID J · 2008 to 2012
$3.5M
REGULATION OF B CELL DEVELOPMENT AND SIGNALING BY BTKR01HD037091 · NICHD · UNIVERSITY OF WASHINGTON · PI RAWLINGS, DAVID J · 1999 to 2008
$2.7M
Lentiviral Gene Therapy of X-Linked AgammaglobulinemiaR01AI084457 · NIAID · SEATTLE CHILDREN'S HOSPITAL · PI RAWLINGS, DAVID J · 2012 to 2015
$2.5M
Lentiviral Gene Therapy for Wiskott-Aldrich SyndromeR56AI071163 · NIAID · SEATTLE CHILDREN'S HOSPITAL · PI RAWLINGS, DAVID J · 2007 to 2007
$615k
Lentiviral Gene Therapy of X-linked AgammaglobulinemiaR56AI084457 · NIAID · SEATTLE CHILDREN'S HOSPITAL · PI RAWLINGS, DAVID J · 2009 to 2009
$398k
NHLBI NIH HHS P01 HL073104NIAID NIH HHS AI071163NIAID NIH HHS R01 AI071163NIAID NIH HHS R01 AI084457NIAID NIH HHS R56 AI071163NIAID NIH HHS R56 AI084457NICHD NIH HHS HD037091NICHD NIH HHS R01 HD037091
6 · The paper itself

Abstract

Transitional and naïve mature peripheral B cells respond very differently to B-cell receptor (BCR) cross-linking. While transitional B cells undergo apoptosis upon BCR engagement, mature B cells survive and proliferate. This differential response correlates with the capacity of mature, but not transitional B cells to transcribe genes that promote cell survival and proliferation, including those encoding c-Myc and the Bcl-2 family members Bcl-xL and A1. We recently demonstrated that transitional B cells fail to assemble transcriptional machinery at the promoter region of these target genes despite equivalent cytoplasmic signaling and nuclear translocation of key transcription factors including NF-κB and nuclear factor of activated T cells (NFAT). The transcription factor myocyte enhancer factor-2C (MEF2C) is regulated by both calcineurin and mitogen-activated protein kinase signaling pathways, and is essential for proliferation and survival downstream of BCR engagement in mature B cells. In this work, we demonstrate that transitional B cells have intrinsically low levels of MEF2C protein and DNA-binding activity, and that this developmental difference in MEF2C expression is functionally significant. Forced expression of MEF2C in transitional B cells promoted cell survival, proliferation, and upregulation of pro-survival genes. Thus, low MEF2C expression limits transitional B-cell responsiveness to BCR engagement before these cells reach maturity.

Indexed as

Gene Expression Regulation, DevelopmentalAnimalsApoptosis Regulatory ProteinsBcl-2-Like Protein 11Cell ProliferationCell SurvivalMEF2 Transcription FactorsMembrane ProteinsMiceMice, Inbred C57BLMice, KnockoutMyogenic Regulatory FactorsPrecursor Cells, B-LymphoidProto-Oncogene ProteinsReceptors, Antigen, B-CellUp-RegulationApoptosis Regulatory ProteinsBcl2l11 protein, mouseBcl-2-Like Protein 11Mef2c protein, mouseMEF2 Transcription FactorsMembrane ProteinsMyogenic Regulatory FactorsProto-Oncogene ProteinsReceptors, Antigen, B-Cell

Identifiers

PMID22311635
PMCPMC3433238
OpenAlexW1885370713

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.